GL Pharm Tech Corp. (KOSDAQ:204840)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,200.00
-8.00 (-0.66%)
Last updated: Jul 16, 2025
17.30%
Market Cap93.05B
Revenue (ttm)28.05B
Net Income (ttm)-680.77M
Shares Out76.97M
EPS (ttm)-8.86
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume81,673
Average Volume193,083
Open1,208.00
Previous Close1,208.00
Day's Range1,190.00 - 1,221.00
52-Week Range900.00 - 1,844.00
Beta0.96
RSI45.20
Earnings DateAug 12, 2025

About GL Pharm Tech

GL Pharm Tech Corp. provides generic drugs and incrementally modified drug (IMD) formulation technology to pharmaceutical companies in South Korea. The company offers IMD for gastritis, antidepressant, anorectic, and antibiotic indications. It also provides generic drugs for cardiovascular, urology, pain, anti-infection, gastric disease, diabetes, central nervous system disease, respiratory disease, transplantation, and other areas. In addition, the company engages in developing new molecule entity pipeline products for dry eye disease. Further... [Read more]

Industry Pharmaceutical Preparations
Founded 2002
Employees 27
Stock Exchange KOSDAQ
Ticker Symbol 204840
Full Company Profile

Financial Performance

In 2024, GL Pharm Tech's revenue was 26.05 billion, an increase of 0.06% compared to the previous year's 26.03 billion. Losses were -2.34 billion, -37.64% less than in 2023.

Financial Statements

News

There is no news available yet.